Nemonoxacin treatment of patients with diabetic foot infection: A pilot study
ConclusionIn this small DFI patient population, nemonoxacin produced excellent clinical and microbiological responses, was well tolerated, and effectively penetrated infected tissues. Once-daily oral nemonoxacin treatment appears effective in DFI patients.NCT registration numberNCT00685698.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
More News: Allergy & Immunology | Diabetes | Endocrinology | Infectious Diseases | Microbiology | MRSA | Staphylococcus Aureus | Study | Superbugs